Quick answer: Without insurance, the lowest self-pay prices for an FDA-approved GLP-1 are the Wegovy pill and Foundayo at $149 a month at the starting dose (medication only; a prescriber visit is extra). The Wegovy and Ozempic pens are $199 for a new patient's first two fills at the starting doses, then $349, and Zepbound starts at $299 through LillyDirect. Compounded semaglutide and tirzepatide are listed from $99 and $125 a month in our table, mostly on prepaid annual plans, but they are not FDA-approved. With commercial insurance that covers the drug, the makers' savings cards can bring the cost to as little as $25; on Medicare, the GLP-1 Bridge is $50 a month for eligible Part D members. We compared 40 options (brand prices re-checked Oct 20, 2026); this is not every provider on the market.
- Lowest FDA-approved price here: the Wegovy pill (1.5 mg) and Foundayo (0.8 mg), $149/mo each at the starting dose, rising with dose. A prescriber visit is extra.
- Lowest price in this comparison: compounded semaglutide at $99/mo, a three-way tie between Cora and Trimi Health (12-month plans, $1,188 upfront) and Eden (month-to-month; Eden describes its fees inconsistently, see its row). Compounded tirzepatide starts at $125/mo (Trimi Health, annual plan). Compounded GLP-1s are not FDA-approved.
- Membership platforms (Sesame, Ro, WeightWatchers Med+, LifeMD, Found, Hims, Hers, Calibrate) sell brand-name drugs, and the total is membership plus medication: $208 to $348/mo at the starting dose.
- Insured or on Medicare? A $25 savings card or the $50 Medicare GLP-1 Bridge can beat every cash price here.
GLP-1 price comparison: 40 options ranked (Oct 2026)
Two tables, in the order most people need them: first what each drug costs (list price, the maker's self-pay price and the insured price), then 40 ways to buy one, ranked by the lowest all-in monthly price.
GLP-1 prices by drug: list price, self-pay and with insurance
Three prices exist for every brand-name GLP-1: the list price the maker sets, the maker's own self-pay price, and what you pay with insurance that covers the drug. Here they are side by side, re-checked on each maker's page Oct 20, 2026.
| Drug | List price | Self-pay (manufacturer or seller) | With commercial insurance |
|---|---|---|---|
| Wegovy pill FDA-approved Novo Nordisk · Daily pill |
$1,349.02 per package | $149 at 1.5 mg, $199 at 4 mg, $299 at 9 and 25 mg | As little as $25/mo (max savings $100/mo) Source: NovoCare Wegovy, checked Oct 20, 2026 |
| Wegovy pen FDA-approved Novo Nordisk · Weekly injection |
$1,349.02 per package | $199 for the first 2 fills at 0.25 or 0.5 mg (new patients, through Dec 31, 2026), then $349; $399 at 7.2 mg | As little as $25/mo (max savings $100/mo) Source: NovoCare Wegovy, checked Oct 20, 2026 |
| Ozempic pen (type 2 diabetes) FDA-approved Novo Nordisk · Weekly injection |
$1,027.51 per pen | $199 for the first 2 fills at 0.25 or 0.5 mg (new patients, through Dec 31, 2026), then $349 at 0.25–1 mg; $499 at 2 mg | As little as $25/mo (max savings $100/mo) Source: NovoCare Ozempic price guide, list price, checked Oct 20, 2026 |
| Foundayo (orforglipron) FDA-approved Eli Lilly · Daily pill |
$649.00 per 30 days | $149 at 0.8 and 2.5 mg, $199 at 5.5 mg (2.5 and 5.5 mg promo prices through Dec 31, 2026), $299 at 9 mg and up (14.5 and 17.2 mg if refilled within 45 days) | As little as $25/mo Source: LillyDirect Foundayo, list price, checked Oct 20, 2026 |
| Zepbound (tirzepatide) FDA-approved Eli Lilly · Weekly injection (vial or KwikPen) |
$499–$1,086.37 per fill | $299 at 2.5 mg, $399 at 5 mg, $449 at 7.5–15 mg if refilled within 45 days ($499–$699 otherwise) | As little as $25 for up to a 3-month fill Source: LillyDirect Zepbound, list price, savings, checked Oct 20, 2026 |
| Mounjaro (type 2 diabetes) FDA-approved Eli Lilly · Weekly injection (single-dose pen) |
$1,112.16 per fill | $499 at every dose | As little as $25 for up to a 3-month fill Source: LillyDirect Mounjaro, list price, savings, checked Oct 20, 2026 |
| Compounded semaglutide or tirzepatide Compounded, not FDA-approved 503A/503B pharmacies · Weekly injection (some tablets) |
None (no list price) | $99–$432/mo all-in at the starting dose in our ranked table (checked Oct 9–20, 2026) | Usually not covered; FSA/HSA may reimburse |
Novo Nordisk says it will cut the list price of Wegovy and Ozempic to $675 a month from Jan 1, 2027, and that the cut does not change its self-pay prices (Novo Nordisk announcement). Ozempic and Mounjaro are approved for type 2 diabetes, not weight management. For dose-by-dose detail on one molecule, see our semaglutide price guide; for how the drugs compared in their trials, see the most effective GLP-1 for weight loss.
40 options ranked by the lowest monthly price
What this cost comparison covers: every seller in our pricing dataset with a dated price, plus the makers' own self-pay programs, 40 options in all. Fella Health is not in the table: it had paused new sign-ups when we checked on Oct 20, 2026. Medvi's compounded tirzepatide is not ranked either: its site showed no tirzepatide price on Oct 20, 2026. It is not every provider on the market. How it is ranked: by the lowest published monthly price at the starting dose, on any plan length, counting every fee the seller requires. A price that needs a prepaid plan is labelled as such, and the month-to-month price sits next to it. Brand self-pay rows (NovoCare, LillyDirect) are medication only; you also need a prescriber. Why 40: one row per seller and drug (one per membership platform, at its lowest brand option); our providers directory lists all 26 sellers and 151 dated prices from the same pricing dataset.
| Provider | Drug, form & status | Lowest monthly, starting dose | Month-to-month / after promo | Price rises with dose? | Billing | Links |
|---|---|---|---|---|---|---|
| 1 Cora | Semaglutide, weekly injection Compounded, not FDA-approved |
$99/mo on the 12-month plan ($1,188 upfront) | $175/mo month-to-month ($145 quarterly, $120 6-month) | No, same price at every dose | Monthly, or prepaid 3, 6 or 12 months. All-inclusive: visit, medication, shipping; no membership | See Cora's prices Source: Cora's plans page, checked Oct 20, 2026 |
| 1 Eden | Semaglutide, weekly injection Compounded, not FDA-approved |
$99/mo month-to-month | Same; no prepaid plan published | No, same price at every dose (except during promotions) | Monthly. Eden's GLP-1 page says there is no separate membership fee, but its Terms of Service (Oct 13) still described a $39 first month, then a $99/mo membership: confirm the total at checkout | Eden prices Source: Eden GLP-1 pricing, checked Oct 13, 2026 |
| 1 Trimi Health | Semaglutide, weekly injection Compounded, not FDA-approved |
$99/mo on the annual plan ($1,188 upfront) | $175/mo month-to-month ($145 quarterly, $120 6-month) | No, same price at every dose | Monthly, or prepaid 3, 6 or 12 months; no membership. The lowest price is on the annual plan | Trimi prices Source: Trimi cost guide, checked Oct 20, 2026 |
| 4 GobyMeds | Semaglutide, weekly injection Compounded, not FDA-approved |
$99.67/mo on a 3-month bundle ($299 upfront) | $169+/mo for a single month | Yes: up to $166.33/mo ($499 per 3-month bundle) at the top dose | 3-month bundle paid up front, or single months; no membership | Our GobyMeds review Source: GobyMeds pricing, checked Oct 11, 2026 |
| 5 Mochi Health | Semaglutide, weekly injection Compounded, not FDA-approved |
$109/mo: $60 medication + $49 membership on the 12-month membership ($588 upfront) | $139/mo ($60 + $79 membership). First month $99 for new patients | Yes: medication $60 to $99 by dose | Medication monthly; membership monthly or prepaid | Our Mochi review Source: Mochi FAQ (membership), per-dose pricing, checked Oct 20, 2026 |
| 6 Trimi Health | Tirzepatide, weekly injection Compounded, not FDA-approved |
$125/mo on the annual plan ($1,500 upfront) | $235/mo month-to-month ($199 quarterly, $175 6-month) | No, same price at every dose | Monthly, or prepaid 3, 6 or 12 months; no membership. The lowest price is on the annual plan | Trimi prices Source: Trimi cost guide, checked Oct 20, 2026 |
| 7 Eden | Tirzepatide, weekly injection Compounded, not FDA-approved |
$129/mo month-to-month | Same; no prepaid plan published | No, same price at every dose (except during promotions) | Monthly. Eden's GLP-1 page says there is no separate membership fee, but its Terms of Service (Oct 13) still described a $39 first month, then a $99/mo membership: confirm the total at checkout | Eden prices Source: Eden GLP-1 pricing, checked Oct 20, 2026 |
| 8 GobyMeds | Tirzepatide, weekly injection Compounded, not FDA-approved |
$133/mo on a 3-month bundle ($399 upfront) | $299+/mo for a single month | Yes: up to $199.67/mo ($599 per 3-month bundle) at the top dose | 3-month bundle paid up front, or single months; no membership | Our GobyMeds review Source: GobyMeds pricing, checked Oct 11, 2026 |
| 9 Amble | Semaglutide or tirzepatide, weekly injection Compounded, not FDA-approved |
$135/mo on the 12-month plan ($1,620 upfront) | $179/mo month-to-month ($160 quarterly; 6 months $135 or $145, the page shows both) | No, same price at every dose | Monthly, or prepaid 3, 6 or 12 months; no membership. One price table for both drugs | Amble prices Source: Amble GLP-1 injections, checked Oct 20, 2026 |
| 9 Cora | Tirzepatide, weekly injection Compounded, not FDA-approved |
$135/mo on the 12-month plan ($1,620 upfront) | $225/mo month-to-month ($199 quarterly, $175 6-month) | No, same price at every dose | Monthly, or prepaid 3, 6 or 12 months. All-inclusive; no membership | See Cora's prices Source: Cora's plans page, checked Oct 20, 2026 |
| 11 Mochi Health | Tirzepatide, weekly injection Compounded, not FDA-approved |
$139/mo: $90 medication + $49 membership on the 12-month membership | $169/mo ($90 + $79 membership). First month $129 for new patients | Yes: medication $90 to $199 by dose | Medication monthly; membership monthly or prepaid | Our Mochi review Source: Mochi FAQ, per-dose pricing, checked Oct 20, 2026 |
| 12 Ivim Health | Semaglutide, weekly injection Compounded, not FDA-approved |
$140/mo: $65 medication on a 12-month program + $75 program fee | No month-to-month plan; only the 12-month program is shown | Plan-priced | 12-month medication program; program fee monthly (first month free) | Our Ivim review Source: Ivim weight-loss pricing, checked Oct 20, 2026 |
| 13 LillyDirect | Foundayo (orforglipron) pill, daily FDA-approved |
$149/mo at 0.8 mg, medication only | Same; no prepaid plan | Yes: $149 at 0.8 and 2.5 mg, $199 at 5.5 mg (2.5 and 5.5 mg promo prices end Dec 31, 2026; regular $199 and $299), $299 at 9 mg and up if refilled within 45 days ($349 otherwise at 14.5 and 17.2 mg) | Monthly self-pay; needs a prescription (prescriber visit not included) | LillyDirect prices Source: LillyDirect Foundayo, checked Oct 20, 2026 |
| 13 NovoCare Pharmacy | Wegovy pill (oral semaglutide), daily FDA-approved |
$149/mo at 1.5 mg, medication only | Same; no prepaid plan | Yes: $199 at 4 mg, $299 at 9 and 25 mg | Monthly self-pay; needs a prescription (prescriber visit not included) | Wegovy cost without insurance · NovoCare prices Source: Wegovy self-pay prices, checked Oct 20, 2026 |
| 15 Fridays | Semaglutide, weekly injection Compounded, not FDA-approved |
$150/mo paid annually ($1,800) | $249/mo month-to-month | Not stated | Monthly or annual; no separate membership. A limited-time promo code ("$99/mo") is left out | Fridays prices Source: Fridays pricing, checked Oct 20, 2026 |
| 16 Shed | Semaglutide, weekly injection Compounded, not FDA-approved |
$159/mo on a 12-month plan ($1,908 upfront) | $199/mo month-to-month ($179 on 6 months) | Not stated | Monthly, or prepaid 6 or 12 months; a prepaid refund re-prices used months at the monthly rate | Our Shed review Source: Shed compounded semaglutide, checked Oct 20, 2026 |
| 17 SkinnyRx | Semaglutide, weekly injection Compounded, not FDA-approved |
$191/mo on a 12-month plan | $249/mo; first month $99 | Not stated | Monthly or prepaid; multi-month prices step up at renewal | Our SkinnyRx review Source: SkinnyRx, checked Oct 11, 2026 |
| 18 Ivim Health | Tirzepatide, weekly injection Compounded, not FDA-approved |
$192/mo: $117 medication on a 12-month program + $75 program fee | No month-to-month plan | Plan-priced | 12-month medication program; program fee monthly (first month free) | Our Ivim review Source: Ivim weight-loss pricing, checked Oct 20, 2026 |
| 19 Henry Meds | Semaglutide, weekly injection Compounded, not FDA-approved |
$197/mo on a 12-month plan paid upfront | $297/mo monthly plan | Priced by the total mg a plan covers (up to 10 mg on the monthly plan) | Monthly, or 6 or 12 months prepaid ($2,364 paid in full); no membership | Our Henry Meds review Source: Henry Meds pricing, programs, checked Oct 13, 2026 |
| 20 Sesame | Wegovy pill or Foundayo pill, daily FDA-approved |
$208/mo: $59 membership on a 12-month commitment ($708) + $149 medication | $248/mo ($99 membership + $149 medication) | Yes, medication rises with dose | Membership monthly or a 12-month commitment; the medication is billed at the maker's self-pay price | Sesame prices Source: Sesame weight-loss program, Foundayo, checked Oct 13, 2026 |
| 21 SkinnyRx | Tirzepatide, weekly injection Compounded, not FDA-approved |
$215/mo on a 12-month plan | $299/mo; first month $99 | Not stated | Monthly or prepaid; multi-month prices step up at renewal | Our SkinnyRx review Source: SkinnyRx, checked Oct 11, 2026 |
| 22 Ro | Wegovy pill or Foundayo pill, daily FDA-approved |
$223/mo: $74 membership on the 12-month plan ($888 upfront) + $149 medication | $298/mo ($149 membership + $149 medication) | Yes, medication rises with dose | Membership monthly or prepaid 3, 6 or 12 months; medication billed on top | Our Ro review · Ro prices Source: Ro pricing, checked Oct 10, 2026 |
| 22 WeightWatchers Med+ | Wegovy pill or Foundayo pill, daily FDA-approved |
$223/mo: $74 membership on the 12-month plan + $149 medication | No month-to-month plan; $233/mo on the 6-month plan; first month $25 | Yes, medication rises with dose | Membership for 6 or 12 months (auto-renews); medication on top | WeightWatchers prices Source: WeightWatchers Med+ pricing, checked Oct 13, 2026 |
| 24 LifeMD | Wegovy pill or other brand GLP-1 FDA-approved |
$224/mo: program from $75 + medication from $149 | $298/mo ($149 program + $149 medication); first program month $39 | Yes, medication rises with dose | Program monthly (auto-renews); medication billed separately | Our LifeMD review · LifeMD prices Source: LifeMD membership page, checked Oct 9, 2026 |
| 25 Henry Meds | Tirzepatide, daily dissolving tablet Compounded, not FDA-approved |
$234/mo on a 12-month plan paid upfront | Not published as a monthly price | Yes, rises as the dose increases | Prepaid; no membership | Our Henry Meds review Source: Henry Meds pricing, checked Oct 20, 2026 |
| 26 Shed | Tirzepatide, weekly injection Compounded, not FDA-approved |
$239/mo on a 12-month plan ($2,868 upfront) | $299/mo month-to-month ($269 on 6 months) | Not stated | Monthly, or prepaid 6 or 12 months; a prepaid refund re-prices used months at the monthly rate | Our Shed review Source: Shed compounded tirzepatide, checked Oct 20, 2026 |
| 27 Fridays | Tirzepatide, weekly injection Compounded, not FDA-approved |
$240/mo paid annually ($2,880) | $359/mo month-to-month | Not stated | Monthly or annual; no separate membership. A limited-time promo code ("as low as $198/mo") is left out | Fridays prices Source: Fridays pricing, checked Oct 20, 2026 |
| 28 Found | Foundayo pill, daily FDA-approved |
$248/mo: $99 membership on the 12-month plan ($1,188 upfront) + $149 medication | $298/mo ($149 membership + $149 medication) | Yes, medication rises with dose | Membership monthly or 12 months upfront; medication billed separately | Our Found review Source: Found offer terms, checked Oct 18, 2026 |
| 29 Noom Med | Semaglutide, weekly injection (full-dose program) Compounded, not FDA-approved |
$249/mo, billed quarterly; Noom app included | No month-to-month plan; first 4 weeks $129 | Not stated; all-inclusive (care, medication, app) | Billed every 12 weeks | Our Noom Med cost guide Source: Noom Med pricing, checked Oct 18, 2026 |
| 30 Hers | Wegovy pill or Ozempic pill, daily FDA-approved |
$298/mo: $149 membership + $149 medication | Same; first month $188 ($39 membership) | Yes, medication rises with dose | Membership monthly (required, no medication included); medication on top | Our Hers review · Hers prices Source: Hers pricing, checked Oct 10, 2026 |
| 30 Hims | Wegovy pill or Ozempic pill, daily FDA-approved |
$298/mo: $149 membership + $149 medication | Same; first month $188 ($39 membership) | Yes, medication rises with dose | Membership monthly (required); medication on top | Our Hims review · Hims prices Source: Hims pricing, checked Oct 10, 2026 |
| 32 LillyDirect | Zepbound (tirzepatide) vial or KwikPen, weekly FDA-approved |
$299/mo at 2.5 mg, medication only | Same; no prepaid plan | Yes: $399 at 5 mg, $449 at 7.5–15 mg if refilled within 45 days | Monthly self-pay; needs a prescription; vials need needles and syringes | Zepbound cost without insurance · LillyDirect prices Source: LillyDirect Zepbound, checked Oct 20, 2026 |
| 32 Medvi | Semaglutide, weekly injection Compounded, not FDA-approved |
$299/mo from month two | Same; first month $149–$179 depending on the landing page | Not stated | Monthly, no contract; no membership on compounded plans | Our Medvi review Source: Medvi pricing, checked Oct 20, 2026 |
| 32 Noom Med | Tirzepatide, weekly injection (GLP-1Rx Plus) Compounded, not FDA-approved |
$299/mo, billed quarterly; Noom app included | No month-to-month plan; first 4 weeks $149 | Not stated; all-inclusive (care, medication, app) | Billed every 12 weeks | Our Noom Med cost guide Source: Noom Med pricing, checked Oct 18, 2026 |
| 32 TrimRx | Semaglutide, weekly injection Compounded, not FDA-approved |
$299/mo per refill | Same; first month $199 | Not stated | Monthly auto-bill, or prepaid; no membership | Our TrimRx review Source: TrimRx terms, checked Oct 20, 2026 |
| 36 Remedy Meds | Semaglutide, weekly injection Compounded, not FDA-approved |
$324/mo: $299 every 4 weeks (13 charges a year) | Same; first fill $179 | Not stated | Billed every 28 days; no membership | Our Remedy Meds review Source: Remedy compounded semaglutide, checked Oct 20, 2026 |
| 37 Calibrate | Wegovy pill, daily (Zepbound also offered) FDA-approved |
$348/mo: $199 membership + $149 medication | Same; 3-month minimum | Yes, medication rises with dose | Membership monthly with a 3-month minimum. Calibrate does not publish a cash drug price; the medication figure is the maker's self-pay price | Calibrate prices Source: Calibrate pricing, checked Oct 11, 2026 |
| 38 NovoCare Pharmacy | Wegovy pen (semaglutide), weekly FDA-approved |
$349/mo; new patients pay $199 for the first 2 fills (through Dec 31, 2026) | Same; no prepaid plan | Flat $349 from 0.25 to 2.4 mg; $399 at 7.2 mg | Monthly self-pay; needs a prescription | NovoCare prices Source: Wegovy self-pay prices, checked Oct 20, 2026 |
| 39 TrimRx | Tirzepatide, weekly injection Compounded, not FDA-approved |
$399/mo per refill | Same; first month $349 | Not stated | Monthly auto-bill, or prepaid; no membership | Our TrimRx review Source: TrimRx terms, checked Oct 20, 2026 |
| 40 Remedy Meds | Tirzepatide, weekly injection Compounded, not FDA-approved |
$432/mo: $399 every 4 weeks (13 charges a year) | Same; first fill $279 | Not stated | Billed every 28 days; no membership | Our Remedy Meds review Source: Remedy compounded tirzepatide, checked Oct 20, 2026 |
Compounded semaglutide and tirzepatide are not FDA-approved, have not been evaluated by the FDA for safety, effectiveness or quality, and are not therapeutically equivalent to Wegovy, Ozempic, Zepbound or Mounjaro. Microdose plans (Henry Meds, Noom) are priced separately and left out because they are not a standard starting dose. Prices change often; the seller's checkout is the final word.
How to get a GLP-1 without insurance: 4 routes
There are four ways people actually pay for a GLP-1 today. Prices below are the ones in the tables above, checked on each seller's or maker's own page (brand prices Oct 20, 2026).
- Manufacturer self-pay (NovoCare Pharmacy, LillyDirect). FDA-approved drugs at the maker's cash price, medication only: the Wegovy pill and Foundayo from $149 a month, the Wegovy pen $199 for a new patient's first two fills then $349, Zepbound from $299 and Mounjaro $499. You need a prescription from any licensed prescriber; the visit is billed separately. Membership platforms such as Ro, Hims, Hers and LifeMD prescribe these same brand drugs and add a fee, for $223 to $298 a month in total at the starting dose.
- A savings card, if you have commercial insurance. When your plan covers the drug, the makers' savings cards can bring Wegovy, Ozempic or Foundayo to as little as $25 a month (Novo caps its saving at $100 a month), and Zepbound or Mounjaro to as little as $25 for up to a 3-month fill. The cards cannot be used with Medicare or Medicaid. If your plan excludes weight-loss drugs, routes 1 and 4 still apply.
- The Medicare GLP-1 Bridge, if you are on Part D. From July 1, 2026 to Dec 31, 2027, eligible Part D members pay a flat $50 a month for Wegovy, the Zepbound KwikPen or Foundayo. Eligibility follows CMS clinical criteria (roughly a BMI of 35 or more, or lower with certain heart or metabolic conditions).
- Compounded telehealth (not FDA-approved). Compounded semaglutide and tirzepatide are listed at $99 to $432 a month all-in at the starting dose in our ranked table (checked Oct 9–20, 2026). Most of the lowest prices need a prepaid plan, usually 12 months; month-to-month prices start at $99 (Eden's semaglutide). Compounded drugs are not FDA-approved, are not the same products as Wegovy or Zepbound, and are made by a pharmacy for an individual patient's prescription.
Uninsured or underinsured and on a low income? Novo Nordisk's and Lilly's patient-assistance programs can supply the drug at no cost if you meet their income limits, so check them before paying cash.
Sticker price vs. all-in cost: why the cheapest headline isn't always the cheapest program
Three things move the real number:
- Plan length. Most of the lowest prices need prepayment: Cora's and Trimi Health's $99 is $1,188 upfront, Ro's $74 membership is $888 upfront. Check the refund terms before you prepay.
- A separate membership fee. Ivim, Mochi, Ro, Hims, Hers, LifeMD, Sesame, WeightWatchers Med+, Found and Calibrate charge a membership on top of the medication. The table adds them together.
- Dose steps. Most prices rise as doses increase. Amble's, Cora's, Eden's and Trimi Health's do not; the brand pills roughly double from the starting dose to the top dose.
Monthly vs 12-month prepaid: what you actually pay in year one
Monthly prices hide two things: dose increases and the prepaid discount. This table adds up 12 months for each option that offers both a monthly and a prepaid price, plus the brand self-pay programs, following each drug's label dose steps where the price changes with dose. The last column shows how long you must stay for prepaying to come out ahead.
| Option | Pay monthly: year one | Lowest prepaid plan: year one | Difference | Prepaying comes out ahead if you stay |
|---|---|---|---|---|
| Cora Semaglutide, weekly injection Compounded, not FDA-approved |
$2,100 12 × $175 |
$1,188 12-month plan, all paid upfront |
$912 | 7 months or more Same price at every dose. Checked Oct 20, 2026 |
| Cora Tirzepatide, weekly injection Compounded, not FDA-approved |
$2,700 12 × $225 |
$1,620 12-month plan, all paid upfront |
$1,080 | 8 months or more Same price at every dose. Checked Oct 20, 2026 |
| Henry Meds Semaglutide, weekly injection Compounded, not FDA-approved |
$3,564 12 × $297 |
$2,364 12-month plan, all paid upfront |
$1,200 | 8 months or more If the price holds; priced by the total mg a plan covers. Checked Oct 20, 2026 |
| LillyDirect Foundayo pill, daily FDA-approved |
$3,188 $149, $149, $199, then 9 fills at $299 |
No prepaid plan | – | – Label dose steps; $3,338 once the 2.5 and 5.5 mg promo prices end Dec 31, 2026. Checked Oct 20, 2026 |
| LillyDirect Zepbound, weekly injection FDA-approved |
$5,188 $299, $399, then 10 fills at $449 |
No prepaid plan | – | – Label dose steps; $449 needs a refill within 45 days. Checked Oct 20, 2026 |
| Mochi Health Semaglutide, weekly injection Compounded, not FDA-approved |
$2,020 $79/mo membership + $1,072 medication |
$1,660 $588 membership upfront + the same medication, billed monthly |
$360 | 8 months or more Mochi's medication price at each label dose step; before first-month offers. Checked Oct 20, 2026 |
| Mochi Health Tirzepatide, weekly injection Compounded, not FDA-approved |
$2,597 $79/mo membership + $1,649 medication |
$2,237 $588 membership upfront + the same medication, billed monthly |
$360 | 8 months or more Mochi's medication price at each label dose step; before first-month offers. Checked Oct 20, 2026 |
| NovoCare Pharmacy Wegovy pill, daily FDA-approved |
$3,338 $149, $199, $299, then 9 fills at $299 |
No prepaid plan | – | – Label dose steps. Checked Oct 20, 2026 |
| NovoCare Pharmacy Wegovy pen, weekly FDA-approved |
$4,188 12 × $349 |
No prepaid plan | – | – Same price from 0.25 to 2.4 mg; $3,888 for a new patient with the $199 first two fills (through Dec 31, 2026). Checked Oct 20, 2026 |
| Ro Wegovy pill, daily FDA-approved |
$5,126 $149/mo membership + $3,338 medication |
$4,226 $888 membership upfront + the same medication, billed monthly |
$900 | 6 months or more NovoCare label dose steps + membership. Checked Oct 10, 2026 |
| Ro Foundayo pill, daily FDA-approved |
$4,976 $149/mo membership + $3,188 medication |
$4,076 $888 membership upfront + the same medication, billed monthly |
$900 | 6 months or more LillyDirect label dose steps at current prices + membership. Checked Oct 10, 2026 |
Coaching and nutrition guidance can help, since the drugs are meant to be used alongside dietary and lifestyle changes. But when comparing programs, get one number: medication + membership + visit, at your likely dose, for the months you will actually stay. The compounded vs. brand GLP-1: a cost comparison goes deeper; drug-by-drug, see semaglutide cost and tirzepatide cost without insurance.
The compounded reality
Every compounded option in the table is cheaper than its brand-name counterpart, and every one is not FDA-approved. Here is what that means, with the FDA's own pages linked.
- Not reviewed the way approved drugs are. The FDA does not review compounded drugs for safety, effectiveness or quality before they are sold, and it has received reports of dosing errors and adverse events with compounded GLP-1s (FDA's concerns with unapproved GLP-1 drugs). The doctors who prescribe it are licensed; the drug itself is not approved.
- 503A vs. 503B. A 503A pharmacy is state-licensed and compounds for an individual patient's prescription. A 503B outsourcing facility registers with the FDA, follows federal manufacturing standards (CGMP), and can make larger batches (FDA compounding Q&A).
- Why it costs less. Compounders skip the clinical trials, brand marketing and patent pricing behind Wegovy and Zepbound; they buy the active ingredient and mix it. The lower price reflects that, not equal evidence.
- What changed when the shortages ended. The FDA declared the tirzepatide shortage over in December 2024 and semaglutide's in February 2025, then ended the grace periods for mass compounding in 2025 (FDA: Policies for compounders as GLP-1 supply stabilizes). Copies of the approved drugs are no longer allowed; a 503A pharmacy may still compound for an individual patient's documented clinical need. In May 2026 the FDA proposed excluding both molecules from 503B bulk compounding (Federal Register, May 1, 2026); as of Oct 20, 2026 it is not final. For semaglutide specifically, see our guide to compounded semaglutide. For tirzepatide, see compounded tirzepatide in 2026.
Compounded semaglutide and tirzepatide are available through every compounded provider in the table, but they are not the same products as Wegovy or Zepbound. If you want the approved drug, the brand rows are FDA-approved branded drugs, not compounded versions; you can also buy Zepbound vials directly through LillyDirect. Every seller's plan ladder and dose terms are in our compounded tirzepatide cost by provider and compounded semaglutide cost by provider tables.
Is cheap always safe? How to evaluate a provider
Before you pay, ask these questions and get written answers:
- Which pharmacy fills it? You want a named and verifiable state-licensed 503A compounding pharmacy (or an FDA-registered 503B facility) you can look up. TrimRx, for one, does not name its pharmacy.
- Is the pharmacy licensed in my state? Check your state board of pharmacy.
- Which salt form? The FDA has warned against salt forms such as semaglutide sodium or acetate, which differ from the approved base.
- What is the all-in monthly charge at my dose, and what are the refund and cancellation terms? Billing and refunds are the top complaint themes in our reviews.
- Does a clinician actually review me? A legitimate program checks clinical eligibility criteria and medical history before prescribing.
Avoid anyone who ships without a prescription, sells "research use only" vials, or says a compounded product is FDA-approved or the same as a brand drug. For more side-by-side detail, see the ranked comparison of compounded GLP-1 telehealth providers and, for tirzepatide, the cheapest compounded tirzepatide online.
Cheapest FDA-approved GLP-1 without insurance
Every price here is the manufacturer's own self-pay price, checked Oct 10, 2026 and re-checked Oct 20, 2026. The cheapest FDA-approved options are the two $149 pills; the cheapest injection is the Wegovy or Ozempic pen at $199 for a new patient's first two fills, then $349, with Zepbound at $299 for the 2.5 mg starting dose. You still need a prescription, and the visit is billed separately.
- Wegovy pill: $149/mo at 1.5 mg, $199 at 4 mg, $299 at 9 and 25 mg (NovoCare's Wegovy cost page).
- Wegovy pen: $349/mo from 0.25 to 2.4 mg; new patients pay $199 for their first two fills at 0.25 or 0.5 mg through Dec 31, 2026. More on the semaglutide price without insurance, dose by dose.
- Foundayo (orforglipron): the first oral GLP-1 for weight that needs no food or water timing, FDA-approved on April 1, 2026; $149/mo at 0.8 mg through LillyDirect; $299 at 9 mg and up if refilled within 45 days, $349 otherwise at the top doses (re-checked Oct 20, 2026).
- Zepbound: $299/mo at 2.5 mg, $399 at 5 mg and $449 at higher doses if refilled within 45 days, through LillyDirect.
- Ozempic and Mounjaro are approved for type 2 diabetes. Ozempic's self-pay pen is $349/mo at 0.25–1 mg; Mounjaro's single-dose pen is $499/mo at every dose through LillyDirect (re-checked Oct 20, 2026).
Drug-by-drug guides: Ozempic cost without insurance, Wegovy cost without insurance and Zepbound cost without insurance.
Cheapest GLP-1 pill
Two FDA-approved GLP-1 pills are sold for weight management, and both start at $149 a month self-pay (checked Oct 20, 2026):
- Wegovy pill (oral semaglutide), NovoCare: $149 at 1.5 mg, $199 at 4 mg, $299 at 9 and 25 mg.
- Foundayo (orforglipron), LillyDirect: $149 at 0.8 and 2.5 mg, $199 at 5.5 mg (the 2.5 and 5.5 mg prices are promotional through Dec 31, 2026), $299 at 9 mg and up; the 14.5 and 17.2 mg prices need a refill within 45 days.
At the starting dose they cost the same. The Wegovy pill reaches $299 at its third step, while Foundayo stays at $149 for its first two steps through the end of 2026. Each dose, with the insurance and Medicare prices, is in our Wegovy pill cost breakdown. The Ozempic pill, approved for type 2 diabetes, is also $149 at 1.5 mg. Compounded tablets are sometimes listed for less but are not FDA-approved. See Foundayo cost for the full dose ladder.
How much is a GLP-1 with insurance?
If your commercial insurance covers a GLP-1, NovoCare and LillyDirect savings cards can bring your cost down to about $25/mo (not usable with Medicare or Medicaid). If you are uninsured or underinsured and meet income limits, Novo Nordisk and Lilly patient-assistance programs can supply the drug at no cost. Either one beats every cash price in the table, so check them first. Without coverage, our GLP-1 cost per month by drug page sets each drug's list price, self-pay price and first-year average side by side. Novo's card for Wegovy and Ozempic caps the saving at $100 a month; Lilly's cards for Zepbound and Mounjaro can cover up to a 3-month fill for $25.
Medicare and coverage options in 2026
The Medicare GLP-1 Bridge (July 1, 2026 to Dec 31, 2027) gives eligible Part D members a flat $50/mo for Wegovy, the Zepbound KwikPen or Foundayo; see the CMS Medicare GLP-1 Bridge page. Many commercial plans still exclude weight-loss GLP-1s; see does insurance cover Wegovy and Zepbound? and how to get a GLP-1 covered by insurance. Paying cash? See using HSA/FSA for a GLP-1.
Compare published GLP-1 prices →
Frequently asked questions
What's the cheapest GLP-1 without insurance?
In our comparison, the lowest published price at the starting dose is $99/mo for compounded semaglutide, shared by Cora and Trimi Health (12-month prepaid plans) and Eden (month-to-month); the lowest FDA-approved options are the Wegovy pill and Foundayo at $149/mo, medication only. Compounded GLP-1s are not FDA-approved.
What's the cheapest way to get semaglutide online?
Among the providers we compared, compounded semaglutide starts at $99/mo (Cora or Trimi Health on a prepaid annual plan, Eden month-to-month), then $99.67/mo on a GobyMeds 3-month bundle, and it is not FDA-approved; the FDA-approved Wegovy pill is $149/mo at 1.5 mg through NovoCare, plus a prescriber visit.
Which GLP-1 is cheapest — Ozempic, Wegovy, Zepbound, or compounded?
At self-pay starting doses: the Wegovy pill is $149/mo, Zepbound vials $299/mo, and the Wegovy and Ozempic pens $349/mo after a $199 intro, while compounded semaglutide and tirzepatide start lower (from $99 and $125/mo in our table) but are not FDA-approved.
Is it safe to buy a GLP-1 online?
It can be, from a licensed telehealth provider that requires a clinician visit and names the state-licensed pharmacy that fills it. The FDA warns about counterfeit and unapproved GLP-1s sold online, so avoid anyone who ships without a prescription or calls a compounded drug FDA-approved.
Does FSA or HSA cover compounded GLP-1?
Often, when it is prescribed to treat a medical condition, since that can be a qualified medical expense; check with your plan administrator first.
How low will GLP-1 prices go in 2026?
Brand self-pay prices now start at $149/mo for the pills, and Medicare's GLP-1 Bridge charges eligible Part D members $50/mo through Dec 31, 2027. No U.S. generic semaglutide or tirzepatide is expected before patents expire in the early 2030s.
What is the cheapest GLP-1 pill?
Foundayo (0.8 mg) and the Wegovy pill (1.5 mg) both start at $149/mo self-pay, and both rise at higher doses. Compounded tablets are sometimes cheaper but are not FDA-approved.
What BMI do I need to qualify for a GLP-1?
Generally a BMI of 30 or more, or 27 or more with a weight-related condition such as high blood pressure. A licensed clinician makes the call.
Is compounded semaglutide still legal in 2026?
Yes, but narrowly: since the shortage ended in February 2025, a state-licensed 503A pharmacy may compound it for an individual patient's documented need, not as a copy of Wegovy. It is not FDA-approved.
How much is Ozempic with a GoodRx coupon or at Costco?
Ozempic's self-pay price through NovoCare is $349/mo at 0.25–1 mg (new patients $199 for two fills); coupon and warehouse prices vary by pharmacy, so compare a few before filling.
Who qualifies for the $50 Medicare GLP-1 Bridge?
Part D members aged 18 or older who meet BMI criteria (roughly 35+, or lower with certain heart or metabolic conditions), through Dec 31, 2027. It covers Wegovy, the Zepbound KwikPen and Foundayo.
What should I do if my insurance denies a GLP-1?
Ask your prescriber for a letter of medical necessity, then file an internal appeal and, if needed, an external review. Self-pay brand programs are the fallback.
What is known as the "poor man's Ozempic"?
The phrase is used online for non-GLP-1 options such as the supplement berberine or the diabetes drug metformin. Neither is a GLP-1 or a substitute for one, so ask a clinician before trying either.
How much does Ozempic cost per month without insurance?
Through NovoCare, the Ozempic pen is $349 a month at 0.25, 0.5 or 1 mg and $499 at 2 mg, and new patients pay $199 for their first two fills at 0.25 or 0.5 mg through Dec 31, 2026 (checked Oct 20, 2026). Ozempic is approved for type 2 diabetes, and its list price is $1,027.51 per pen.
Can I pay for a GLP-1 monthly?
Yes: NovoCare and LillyDirect bill brand self-pay month by month, and most telehealth programs in our table offer a monthly plan. The lowest prices usually need a 3- to 12-month prepaid plan, so compare the month-to-month column before you commit.
Which GLP-1 is the most expensive?
By list price, Wegovy is the highest at $1,349.02 per package, ahead of Mounjaro ($1,112.16 per fill), Zepbound (up to $1,086.37 per fill), Ozempic ($1,027.51 per pen) and Foundayo ($649 per 30 days). Self-pay prices are far lower, from $149 to $499 a month.
What's the cheapest alternative to Ozempic?
Among FDA-approved options, the Wegovy pill and Foundayo start at $149 a month self-pay, and the Ozempic pill (for type 2 diabetes) also starts at $149. Compounded semaglutide is listed from $99 a month in our table but is not FDA-approved and is not the same product as Ozempic.
What is the cheapest way to get GLP-1 medication?
With commercial insurance that covers the drug, a maker's savings card (as little as $25 a month) or, on Medicare Part D, the $50 GLP-1 Bridge is usually the cheapest way; without coverage, the lowest FDA-approved self-pay prices are the Wegovy pill and Foundayo at $149 a month (checked Oct 20, 2026). Compounded semaglutide is listed from $99 a month in our table (month-to-month at one seller, on 12-month prepaid plans at two others), but it is not FDA-approved.
How do I get Ozempic for $25 a month?
You need commercial insurance that covers Ozempic plus Novo Nordisk's savings card, which can bring the cost to as little as $25 a month, with savings capped at $100 a month (checked Oct 20, 2026). The card cannot be used with Medicare or Medicaid; without coverage, Ozempic is $349 a month self-pay at 0.25 to 1 mg through NovoCare.
What can I do if I can't afford GLP-1?
Check the cheaper routes first: a maker's savings card if your commercial plan covers the drug, the $50 Medicare GLP-1 Bridge if you are an eligible Part D member, or Novo Nordisk's and Lilly's patient-assistance programs if you meet their income limits. If none apply, the lowest FDA-approved self-pay prices are $149 a month for the Wegovy pill or Foundayo, and an appeal with a letter of medical necessity can help if your insurer denied coverage.
Where can I buy GLP-1 pills?
With a prescription, you can buy the Wegovy pill from NovoCare Pharmacy and Foundayo from LillyDirect, each $149 a month at the starting dose (checked Oct 20, 2026). Telehealth platforms such as Ro, Hims, Hers and LifeMD also prescribe GLP-1 pills and add a membership, for $223 to $298 a month in total at the starting dose; avoid any seller that ships without a prescription.
What is the cheapest way to get Wegovy without insurance?
The Wegovy pill through NovoCare Pharmacy is the cheapest self-pay Wegovy, at $149 a month for the 1.5 mg starting dose and up to $299 at higher doses (checked Oct 20, 2026). The Wegovy pen is $199 for a new patient's first two fills at 0.25 or 0.5 mg through Dec 31, 2026, then $349 a month, and eligible Medicare Part D members can get Wegovy for $50 a month through the GLP-1 Bridge.
How much does Ozempic 1mg cost?
Without insurance, Ozempic 1 mg costs $349 a month through NovoCare Pharmacy, the same as the 0.25 and 0.5 mg doses, while 2 mg is $499 (checked Oct 20, 2026). Its list price is $1,027.51 per pen, and with commercial coverage and Novo's savings card it can be as little as $25 a month.
Will GLP-1 get cheaper?
List prices are coming down: Novo Nordisk says it will cut the Wegovy and Ozempic list price to $675 a month from Jan 1, 2027, though it says its self-pay prices will not change. Some promotional self-pay prices end Dec 31, 2026 (NovoCare's $199 first fills, Foundayo's 2.5 and 5.5 mg prices), and no U.S. generic semaglutide or tirzepatide is expected before patents expire in the early 2030s.
The bottom line
The lowest FDA-approved prices are the Wegovy pill and Foundayo at $149/mo at the starting dose. In our comparison, the lowest published price overall is $99/mo for compounded semaglutide, shared by Cora, Eden and Trimi Health, which is not FDA-approved. If you have insurance or Medicare, a savings card or the $50 Bridge may cost less than anything here. Whatever you choose, compare the all-in monthly price at your likely dose, the plan length you are committing to, and the pharmacy behind it. See what licensed providers charge.
Sources & references
- Provider prices: each seller's own site, linked in the table, checked Oct 9–20, 2026.
- FDA: Human Drug Compounding
- FDA: Postmarket Drug Safety — GLP-1 unapproved product concerns
- FDA: Policies for compounders as GLP-1 supply stabilizes
- FDA: Proposal to exclude semaglutide, tirzepatide, and liraglutide from the 503B bulk-substance list (proposed May 2026)
- NIDDK: Prescription medications to treat overweight and obesity
- CMS: Medicare GLP-1 Bridge — $50/month program (launched July 1, 2026).
- Wegovy self-pay pricing — NovoCare (checked Oct 10, 2026; re-checked Oct 20, 2026).
- Wegovy list and self-pay prices — NovoCare (checked Oct 20, 2026).
- Ozempic pill and pen price guide — NovoCare (checked Oct 20, 2026).
- Ozempic list price — NovoCare (checked Oct 20, 2026).
- Novo Nordisk: Wegovy and Ozempic list price reduction to $675/month from Jan 1, 2027.
- Foundayo self-pay prices — LillyDirect (checked Oct 20, 2026).
- Mounjaro self-pay prices — LillyDirect (checked Oct 20, 2026).
- List prices for Zepbound, Mounjaro and Foundayo: Lilly pricing information (Zepbound, Mounjaro, Foundayo), checked Oct 20, 2026.
- Zepbound self-pay vials — LillyDirect (checked Oct 10, 2026; re-checked Oct 20, 2026).
- Eli Lilly: FDA approves Foundayo (orforglipron), oral GLP-1 pill for weight management (April 1, 2026).
- Wilding JPH et al. Once-Weekly Semaglutide in Adults with Overweight or Obesity (STEP 1). NEJM, 2021.
- Jastreboff AM et al. Tirzepatide Once Weekly for the Treatment of Obesity (SURMOUNT-1). NEJM, 2022.
- Lincoff AM et al. Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes (SELECT). NEJM, 2023.
Compounded semaglutide and tirzepatide are not FDA-approved, have not been evaluated by the FDA for safety, effectiveness or quality, and are not therapeutically equivalent to Wegovy, Ozempic, Zepbound or Mounjaro. Not medical advice. Nouri is a publisher; it does not prescribe or sell any medication.
Disclosure: Nouri may earn a commission when you sign up with some of the providers we link to. It doesn't change what you pay or how we rank providers. Every position in the table follows the method above. Full disclosure.
Medical Disclaimer: This article is for informational purposes only and does not constitute medical advice. Nouri is an independent publisher: it does not prescribe, review patient assessments, or sell medication. Talk to a licensed clinician before starting or changing any medication or treatment.
Compare licensed GLP-1 providers
Published cash prices side by side, with the month we checked them and a link to each provider's own site. Nouri doesn't prescribe or sell medication.